E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/20/2016 in the Prospect News Structured Products Daily.

New Issue: Barclays prices $7.79 million of phoenix autocallables on three funds

By Devika Patel

Knoxville, Tenn., Dec. 20 – Barclays Bank plc priced $7.79 million of phoenix autocallable notes due Dec. 20, 2018 linked to the least-performing of the iShares Nasdaq Biotechnology ETF, the Financial Select Sector SPDR Fund and the Technology Select Sector SPDR Fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annualized rate of 14.1% if each fund closes at or above the barrier level – 75% of the initial price – on the observation date for that quarter.

The notes will be called at par plus the contingent coupon if each fund closes at or above the initial price on any observation date after March 16, 2017.

The payout at maturity will be par plus the contingent coupon unless the least-performing fund finishes below the 75% barrier level, in which case investors will lose 1% for each 1% decline of the least-performing fund.

Barclays is the agent.

Issuer:Barclays Bank plc
Issue:Phoenix autocallable notes
Underlyings:iShares Nasdaq Biotechnology ETF, the Financial Select Sector SPDR Fund and the Technology Select Sector SPDR Fund
Amount:$7,791,000
Maturity:Dec. 20, 2018
Coupon:14.1%, payable quarterly if each fund closes at or above barrier level on observation date for that quarter
Price:Par
Payout at maturity:Par plus contingent coupon unless least-performing fund finishes below 75% barrier level, in which case 1% loss for each 1% decline
Call:Automatically at par plus contingent coupon if each fund closes at or above initial price on any observation date after March 16, 2017
Initial levels:$272.42 for iShares Nasdaq Biotechnology, $23.36 for Financial Select Sector and $48.59 for Technology Select Sector
Barrier levels:$204.32 for iShares Nasdaq Biotechnology, $17.52 for Financial Select Sector and $36.44 for Technology Select Sector; 75% of initial levels
Pricing date:Dec. 16
Settlement date:Dec. 21
Agents:Barclays
Fees:1.75%
Cusip:06741VFK3

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.